BWM
PRCT icon

Benson Wealth Management’s Procept Biorobotics PRCT Stock Holding History

Benson Wealth Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Hold
72
– – ﹤0.01% 303
2026
Q1 		$1.8K Hold
72
– – ﹤0.01% 280
2025
Q4 		$2.27K Buy
+72
New +$2.39K ﹤0.01% 256

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Benson Wealth Management's PRCT Position: Q2 2026 in Review

Benson Wealth Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 72 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

Benson Wealth Management first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.27K in Q4 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Benson Wealth Management held 72 shares of Procept Biorobotics worth $1.63K as of Q2 2026.
  • Benson Wealth Management left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Benson Wealth Management's portfolio in Q2 2026, its #303 holding.
  • Benson Wealth Management first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • Benson Wealth Management's Procept Biorobotics position peaked at $2.27K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Benson Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.